Suppression of T-lymphocyte proliferation by sulphonamide hydroxylamines
Authors:
- Erin SissonESErin Sisson
- Ingrid A. BirdIBIngrid A. Bird
- Wassim Y. AlmawiWAWassim Y. Almawi
- 1 October 1992
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (7) , 1175-1180
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cellular toxicity of sulfamethoxazole reactive metabolites—I: Inhibition of intracellular esterase activity prior to cell deathBiochemical Pharmacology, 1991
- Diagnosis of Sulfonamide Hypersensitivity Reactions by In-Vitro "Rechallenge" with Hydroxylamine MetabolitesAnnals of Internal Medicine, 1989
- Contingent Genetic Regulatory Events in T Lymphocyte ActivationScience, 1989
- New clues about T-cell antigen receptor complex functionImmunology Today, 1988
- Drug disposition and drug hypersensitivityBiochemical Pharmacology, 1987
- Differences in Metabolism of Sulfonamides Predisposing to Idiosyncratic ToxicityAnnals of Internal Medicine, 1986
- In vitro evaluation of a toxic metabolite of sulfadiazineCanadian Journal of Physiology and Pharmacology, 1985
- Overview. Trimethoprim-Sulfamethoxazole: An Assessment of More Than 12 Years of UseClinical Infectious Diseases, 1982